✦ LIBER ✦

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study

✍ Scribed by Dean J Kereiakes, Steven G Chrysant, Joseph L Izzo Jr, Thomas Littlejohn III, Michael Melino, James Lee, Victor Fernandez, Reinilde Heyrman

Book ID: 119900343
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 344 KB
Volume: 11
Category: Article
ISSN: 1475-2840
DOI: 10.1186/1475-2840-11-134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triple therapy with olmesartan medoxomil

Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study

✍ Suzanne Oparil; Michael Melino; James Lee; Victor Fernandez; Reinilde Heyrman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

✍ Karthik Ananthasubramaniam; Robert Weiss; Bruce McNutt; Barbara Klauke; Kathleen 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 333 KB

Dose-Finding Study of Bixalomer in Patie

Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study

✍ Akizawa, Tadao; Origasa, Hideki; Kameoka, Chisato; Kaneko, Yuichiro; Kanoh, Hiro 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB